Opaleye Management as of March 31, 2015
Portfolio Holdings for Opaleye Management
Opaleye Management holds 37 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Chimerix (CMRX) | 9.9 | $21M | 565k | 37.69 | |
| Cempra | 8.0 | $17M | 500k | 34.31 | |
| Ariad Pharmaceuticals | 5.7 | $12M | 1.5M | 8.24 | |
| Retrophin | 5.6 | $12M | 500k | 23.96 | |
| Clovis Oncology | 4.8 | $10M | 140k | 74.23 | |
| AMAG Pharmaceuticals | 4.8 | $10M | 190k | 54.66 | |
| Agios Pharmaceuticals (AGIO) | 3.9 | $8.5M | 90k | 94.30 | |
| Codexis (CDXS) | 3.6 | $7.9M | 1.7M | 4.56 | |
| Geron Corporation (GERN) | 3.2 | $6.9M | 1.8M | 3.77 | |
| Medgenics Com New | 3.2 | $6.9M | 850k | 8.06 | |
| Ultragenyx Pharmaceutical (RARE) | 3.2 | $6.8M | 110k | 62.09 | |
| Supernus Pharmaceuticals (SUPN) | 3.0 | $6.5M | 535k | 12.09 | |
| Tetraphase Pharmaceuticals | 3.0 | $6.4M | 175k | 36.64 | |
| Insys Therapeutics Com New | 3.0 | $6.4M | 110k | 58.13 | |
| MiMedx (MDXG) | 2.8 | $6.1M | 590k | 10.40 | |
| Fibrogen | 2.8 | $6.0M | 191k | 31.38 | |
| Neurocrine Biosciences (NBIX) | 2.7 | $5.8M | 145k | 39.71 | |
| Imprimis Pharmaceuticals Com New | 2.5 | $5.5M | 687k | 7.99 | |
| Flamel Technologies Sa Sponsored Adr | 2.5 | $5.4M | 300k | 17.98 | |
| Trillium Therapeutics Com New | 2.4 | $5.3M | 260k | 20.23 | |
| Ophthotech | 2.3 | $4.9M | 105k | 46.53 | |
| Adamas Pharmaceuticals | 2.1 | $4.5M | 255k | 17.49 | |
| Kite Pharma | 2.0 | $4.4M | 76k | 57.68 | |
| Amarin Corp Sponsored Adr New | 1.9 | $4.1M | 1.8M | 2.34 | |
| Axogen (AXGN) | 1.6 | $3.5M | 986k | 3.50 | |
| Cara Therapeutics | 1.5 | $3.2M | 315k | 10.05 | |
| Zs Pharma | 1.5 | $3.2M | 75k | 42.08 | |
| Lion Biotechnologies | 1.1 | $2.4M | 200k | 12.11 | |
| Accelr8 Technology | 1.1 | $2.3M | 101k | 22.50 | |
| Tenax Therapeutics | 0.9 | $2.0M | 606k | 3.26 | |
| Evoke Pharma | 0.8 | $1.7M | 245k | 7.05 | |
| Macrogenics (MGNX) | 0.7 | $1.6M | 50k | 31.38 | |
| BioDelivery Sciences International | 0.7 | $1.5M | 141k | 10.50 | |
| Celgene Corp Right 12/31/2030 | 0.7 | $1.5M | 490k | 2.97 | |
| Biolinerx Sponsored Adr | 0.2 | $528k | 250k | 2.11 | |
| Inspiremd Com New | 0.2 | $400k | 1.3M | 0.32 | |
| Tracon Pharmaceuticals | 0.1 | $171k | 12k | 14.05 |
